Bcl-2 protein Noxa in human T cell metabolism and differentiation
Bcl-2 protein Noxa in human T cell metabolism and differentiation
批准号:
10197022
负责人:
AMEETA KELEKAR
金额:
$18.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-18 至 2023-05-31
关键词:
AdoptedAffectAntigen ReceptorsApoptoticAutomobile DrivingBCL-2 ProteinBCL2 geneBiochemicalBiological AssayBiomassCD8-Positive T-LymphocytesCRISPR/Cas technologyCarbonCell Differentiation processCell physiologyCellsCellular Metabolic ProcessCitric Acid CycleClonal ExpansionClustered Regularly Interspaced Short Palindromic RepeatsDataDependenceEnergy-Generating ResourcesEventExhibitsFamilyFatty AcidsFlow CytometryGenerationsGluconeogenesisGlucoseGlutaminaseGlutamineGoalsGrowthHematologic NeoplasmsHumanImmuneImmune responseImmunotherapeutic agentImmunotherapyImpairmentInvadedKnowledgeLeukemic CellLinkLymphocyteMediatingMemoryMessenger RNAMetabolicMetabolic PathwayMetabolismMicroRNAsMitochondriaMusOrganismOxidative PhosphorylationPathway interactionsPhenotypePlayPopulationPositioning AttributePost-Transcriptional RegulationProliferatingPropertyProtein BiosynthesisProtein FamilyProteinsProteomeRegulationRegulatory PathwayRegulatory T-LymphocyteResearchResearch PersonnelRoleSignal PathwaySignal TransductionSignaling MoleculeSourceSupporting CellT cell differentiationT memory cellT-Cell ActivationT-LymphocyteTestingTherapeuticTracerWorkacute T-cell lymphoblastic leukemia cellaerobic glycolysiscancer cellcellular targetingeffector T cellfatty acid oxidationglucose uptakeinsightinterestleukemiamembermetabolic phenotypemetabolomicsmitochondrial fitnessnoveloxidationpreventprogramssugartherapy outcometooluptake
中文摘要
总结
幼稚淋巴细胞在接收到适当的共刺激信号后,被激活并经历一个周期。
快速增殖爆发,然后承担效应子功能,直接杀死目标“入侵”生物体,或
癌细胞这种快速的增殖爆发需要增加葡萄糖的摄取和利用,
产生生物质的基本单元的途径。为了支持增殖,激活的T细胞切换到
谷氨酰胺作为氧化磷酸化(OXPHOS)的碳源。向有氧糖酵解的转变,
活化T细胞对谷氨酰胺的依赖性增强已得到充分证明,但信号通路
促进这一转变的因素却知之甚少。
我们小组最近的研究指出,人类Bcl-2家族BH 3蛋白Noxa在控制
这种激活诱导的T细胞代谢转换。BH 3-only蛋白是促凋亡蛋白,但Noxa
在白血病细胞中也表现出促生长和存活功能。Noxa的这个非正则函数是
在原代人T淋巴细胞中也是明显的。Noxa在TCR后T细胞中显著上调
参与,并保持高的活化细胞增殖。此外,它还需要持续提供
谷氨酰胺保持高表达。早期的研究表明,Noxa在T细胞活化中起着重要作用
以及与激活相关的代谢重编程。我们将检验一个中心假设,即-
Noxa是活化的人T细胞代谢转换为γ-氨基裂解及其分化所必需的
到效应子表型。
第一个目标是研究Noxa在T细胞活化和谷氨酰胺代谢中的作用。我们将确定
谷氨酰胺是否通过调节microRNA介导T细胞中Noxa表达的诱导。这
本研究还将检验Noxa是γ-氨基裂解和活化T细胞增殖所必需的假说
使用新的CRISPR产生的Noxa KO原代T细胞,生物化学测定,代谢表型,
代谢组学尽管Noxa的缺失会损害线粒体氨解,但它并不影响线粒体的适应性,这表明
受刺激的T细胞转变为氧化磷酸化的替代燃料源。在Aim 2中,我们将使用多-
参数流式细胞术,以及代谢和功能测定,以检验Noxa使T
通过促进γ-氨基裂解产生效应细胞,并阻止T细胞分化为调节性T细胞(Treg)
或记忆(TM)表型。
了解T细胞在扩增过程中的代谢需求将有助于发展
针对代谢的治疗策略。这项研究可以揭示利用串扰的途径
Noxa和谷氨酰胺代谢之间的关系,以更好地了解驱动代谢转换的细胞事件
在T细胞中。这项拟议的工作还将深入了解Noxa在驱动T细胞分化为T细胞中的作用。
效应子,调节或记忆亚型,并帮助评估蛋白质作为治疗工具的潜力。
英文摘要
SUMMARY
Naïve lymphocytes, upon receiving appropriate co-stimulatory signals, become activated and go through a
rapid proliferative burst before assuming effector functions directed at killing the target ‘invading’ organism or
cancer cell. This rapid proliferative burst requires increased uptake and utilization of glucose in anabolic
pathways that produce building blocks for biomass. To support proliferation activated T cells switch to
glutamine as the carbon source for oxidative phosphorylation (OXPHOS). The shift to aerobic glycolysis and
enhanced dependence on glutamine in activated T cells is well documented, but the signaling pathways
that facilitate this shift are poorly understood.
Recent studies from our group point to a key role for human Bcl-2 family BH3-only protein, Noxa, in controlling
this activation-induced metabolic switch in T cells. BH3-only proteins are by definition pro-apoptotic, but Noxa
exhibits a pro-growth and survival function as well, in leukemia cells. This non-canonical function of Noxa is
also evident in primary human T lymphocytes. Noxa is significantly upregulated in T cells following TCR
engagement, and remains high as the activated cells proliferate. Additionally, it requires constant availability of
glutamine to remain highly expressed. Early studies suggest that Noxa plays an essential role in T cell activation
and the metabolic reprogramming associated with activation. We will test a central hypothesis that states -
Noxa is required for the metabolic switch to glutaminolysis in activated human T cells and for their differentiation
to the effector phenotype.
The first aim will investigate the role of Noxa in T cell activation and glutamine metabolism. We will determine
whether glutamine mediates the induction of Noxa expression in T cells through regulation of microRNAs. This
aim will also test the hypothesis that Noxa is required for glutaminolysis and for proliferation of activated T cells
using novel CRISPR-generated Noxa KO primary T cells, biochemical assays, metabolic phenotyping, and
metabolomics. Although loss of Noxa impairs glutaminolysis, it does not affect mitochondrial fitness suggesting
stimulated T cells shift to an alternative fuel source for oxidative phosphorylation. In Aim 2 we will use multi-
parameter flow cytometry, and metabolic and functional assays to test the hypothesis that Noxa enables T
effector cell generation by promoting glutaminolysis, and prevents differentiation of T cells to a regulatory (Treg)
or memory (TM) phenotype by suppressing fatty acid oxidation.
An understanding of the metabolic needs of T cells as they undergo expansion will help to develop
therapeutic strategies targeted at metabolism. This research could reveal avenues to exploit the crosstalk
between Noxa and glutamine metabolism to better understand cellular events that drive the metabolic switch
in T cells. The proposed work also will offer insights into Noxa’s role in driving differentiation of T cells into
effector, regulatory or memory subtypes and help evaluate the protein’s potential as a therapeutic tool.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role for gluconeogenic enzyme FBP1 in T cell activation
-
批准号:10554289
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2022
-
负责人:AMEETA KELEKAR
-
依托单位:
Role for gluconeogenic enzyme FBP1 in T cell activation
-
批准号:10433367
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2022
-
负责人:AMEETA KELEKAR
-
依托单位:
Bcl-2 protein Noxa in human T cell metabolism and differentiation
-
批准号:10064173
-
项目类别:
-
资助金额:$21.77万
-
财政年份:2020
-
负责人:AMEETA KELEKAR
-
依托单位:
Role of a pro-apoptotic Bcl-2 protein in the survival and death of leukemia cells
-
批准号:8460563
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2011
-
负责人:AMEETA KELEKAR
-
依托单位:
Role of a pro-apoptotic Bcl-2 protein in the survival and death of leukemia cells
-
批准号:8083459
-
项目类别:
-
资助金额:$29.91万
-
财政年份:2011
-
负责人:AMEETA KELEKAR
-
依托单位:
Role of a pro-apoptotic Bcl-2 protein in the survival and death of leukemia cells
-
批准号:8298981
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2011
-
负责人:AMEETA KELEKAR
-
依托单位:
Role of a pro-apoptotic Bcl-2 protein in the survival and death of leukemia cells
-
批准号:8835063
-
项目类别:
-
资助金额:$30.53万
-
财政年份:2011
-
负责人:AMEETA KELEKAR
-
依托单位:
Role of a pro-apoptotic Bcl-2 protein in the survival and death of leukemia cells
-
批准号:8657904
-
项目类别:
-
资助金额:$29.62万
-
财政年份:2011
-
负责人:AMEETA KELEKAR
-
依托单位:
海外基金